COST-UTILITY ANALYSIS OF 10-AND 13-VALENT PNEUMOCOCOCCAL CONJUGATE VACCINES IN THE PHILIPPINES

被引：0
|
作者：
Haasis, M. A. [1 ]
Ceria, J. A. [1 ]
机构：
[1] Dept Hlth, Manila, Philippines
来源：
VALUE IN HEALTH | 2014年 / 17卷 / 07期
关键词：
D O I：
10.1016/j.jval.2014.08.526
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PIN26
引用
收藏
页码：A807 / A807
页数：1
相关论文
共 50 条
  • [31] The impact of 10-valent and 13-valent pneumococcal conjugate vaccines on serotype 19A invasive pneumococcal disease
    Principi, Nicola
    Esposito, Susanna
    EXPERT REVIEW OF VACCINES, 2015, 14 (10) : 1359 - 1366
  • [32] Cost-effectiveness analysis of replacing the 10-valent pneumococcal conjugate vaccine (PCV10) with the 13-valent pneumococcal conjugate vaccine (PCV13) in Brazil infants
    Perdrizet, Johnna
    Santana, Carlos Felipe S.
    Senna, Thais
    Alexandre, Rodrigo Fernandes
    de Almeida, Rodrigo Sini
    Spinardi, Julia
    Wasserman, Matt
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2021, 17 (04) : 1162 - 1172
  • [33] COST-EFFECTIVENESS OF 13-VALENT AND 10-VALENT PNEUMOCOCCAL CONJUGATE VACCINATION RELATIVE TO 7-VALENT PNEUMOCOCCAL CONJUGATE VACCINATION IN CANADA
    Whillans, F.
    Kwan, H.
    Strutton, D. R.
    Earnshaw, S. R.
    Farkouh, R.
    VALUE IN HEALTH, 2009, 12 (07) : A425 - A425
  • [34] Efficacy and effectiveness of ten-valent versus 13-valent pneumococcal conjugate vaccines Reply
    Goldblatt, David
    Madhi, Shabir A.
    LANCET INFECTIOUS DISEASES, 2019, 19 (07): : 693 - 694
  • [35] Cost-effectiveness of 13-valent pneumococcal conjugate vaccination in Mongolia
    Sundaram, Neisha
    Chen, Cynthia
    Yoong, Joanne
    Luvsan, Munkh-Erdene
    Fox, Kimberley
    Sarankhuu, Amarzaya
    La Vincente, Sophie
    Jit, Mark
    VACCINE, 2017, 35 (07) : 1055 - 1063
  • [36] The risk of febrile seizures following influenza and 13-valent pneumococcal conjugate vaccines
    Baker, Meghan
    Jankosky, Christopher
    Yih, W. Katherine
    Gruber, Susan
    Li, Lingling
    Cocoros, Noelle M.
    Lipowicz, Hana
    Coronel-Moreno, Claudia
    DeLuccia, Sandra
    Lin, Nancy D.
    McMahill-Walraven, Cheryl N.
    Menschik, David
    Selvan, Mano S.
    Selvam, Nandini
    Tilney, Rong Chen
    Zichittella, Lauren
    Lee, Grace M.
    Kawai, Alison Tse
    VACCINE, 2020, 38 (09) : 2166 - 2171
  • [37] Kawasaki Disease Following the 13-valent Pneumococcal Conjugate Vaccine and Rotavirus Vaccines
    Kamidani, Satoshi
    Panagiotakopoulos, Lakshmi
    Licata, Charles
    Daley, Matthew F.
    Yih, W. Katherine
    Zerbo, Ousseny
    Tseng, Hung Fu
    DeSilva, Malini B.
    Nelson, Jennifer C.
    Groom, Holly C.
    Williams, Joshua T. B.
    Hambidge, Simon J.
    Donahue, James G.
    Belay, Ermias D.
    Weintraub, Eric S.
    PEDIATRICS, 2022, 150 (06)
  • [38] Cost-effectiveness of 13-valent pneumococcal conjugate vaccine in Switzerland
    Blank, Patricia R.
    Szucs, Thomas D.
    VACCINE, 2012, 30 (28) : 4267 - 4275
  • [39] COST-EFFECTIVENESS OF 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINATION IN KAZAKHSTAN
    Bektur, C.
    Nurgozhin, T.
    VALUE IN HEALTH, 2015, 18 (03) : A106 - A106
  • [40] Immunogenicity and seroefficacy of 10-valent and 13-valent pneumococcal conjugate vaccines: a systematic review and network meta-analysis of individual participant data
    Feng, Shuo
    McLellan, Julie
    Pidduck, Nicola
    Roberts, Nia
    Higgins, Julian P. T.
    Choi, Yoon
    Izu, Alane
    Jit, Mark
    Madhi, Shabir A.
    Mulholland, Kim
    Pollard, Andrew J.
    Temple, Beth
    Voysey, Merryn
    ECLINICALMEDICINE, 2023, 61
12345